-
公开(公告)号:US08063248B2
公开(公告)日:2011-11-22
申请号:US11963838
申请日:2007-12-23
申请人: Charles D. Smith , Kevin J. French , Yan Zhuang
发明人: Charles D. Smith , Kevin J. French , Yan Zhuang
IPC分类号: C07C233/59 , C07C233/57 , C07C233/63 , A61K31/165
CPC分类号: C07C61/39 , C07C49/323 , C07C49/563 , C07C49/567 , C07C49/573 , C07C61/40 , C07C69/738 , C07C211/27 , C07C211/29 , C07C211/48 , C07C211/52 , C07C215/76 , C07C217/58 , C07C217/60 , C07C233/49 , C07C233/59 , C07C233/60 , C07C233/62 , C07C255/44 , C07C255/56 , C07C275/30 , C07C317/32 , C07C323/40 , C07C2601/02 , C07C2603/74 , C07D207/09 , C07D207/27 , C07D209/08 , C07D209/86 , C07D209/88 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/89 , C07D233/24 , C07D233/64 , C07D257/04 , C07D263/58 , C07D277/42 , C07D277/46 , C07D277/82 , C07D295/027 , C07D295/13 , C07D295/30 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D487/04
摘要: The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
摘要翻译: 本发明涉及取代的金刚烷化合物,其药物组合物,其制备方法和抑制鞘氨醇激酶以及治疗或预防过度增殖性疾病,炎性疾病或血管生成疾病的方法。
-
公开(公告)号:US07338961B2
公开(公告)日:2008-03-04
申请号:US11424423
申请日:2006-06-15
申请人: Charles D. Smith , Kevin J. French , Yan Zhuang
发明人: Charles D. Smith , Kevin J. French , Yan Zhuang
IPC分类号: C07D211/68 , C07D211/80 , A01N43/40 , A61K31/435
CPC分类号: C07C61/39 , C07C49/323 , C07C49/563 , C07C49/567 , C07C49/573 , C07C61/40 , C07C69/738 , C07C211/27 , C07C211/29 , C07C211/48 , C07C211/52 , C07C215/76 , C07C217/58 , C07C217/60 , C07C233/49 , C07C233/59 , C07C233/60 , C07C233/62 , C07C255/44 , C07C255/56 , C07C275/30 , C07C317/32 , C07C323/40 , C07C2601/02 , C07C2603/74 , C07D207/09 , C07D207/27 , C07D209/08 , C07D209/86 , C07D209/88 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/89 , C07D233/24 , C07D233/64 , C07D257/04 , C07D263/58 , C07D277/42 , C07D277/46 , C07D277/82 , C07D295/027 , C07D295/13 , C07D295/30 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D487/04
摘要: The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
摘要翻译: 本发明涉及取代的金刚烷化合物,其药物组合物,其制备方法和抑制鞘氨醇激酶以及治疗或预防过度增殖性疾病,炎性疾病或血管生成疾病的方法。
-
公开(公告)号:US08557800B2
公开(公告)日:2013-10-15
申请号:US13277044
申请日:2011-10-19
申请人: Charles D. Smith , Kevin J. French , Yan Zhuang
发明人: Charles D. Smith , Kevin J. French , Yan Zhuang
IPC分类号: A61K31/165
CPC分类号: C07C61/39 , C07C49/323 , C07C49/563 , C07C49/567 , C07C49/573 , C07C61/40 , C07C69/738 , C07C211/27 , C07C211/29 , C07C211/48 , C07C211/52 , C07C215/76 , C07C217/58 , C07C217/60 , C07C233/49 , C07C233/59 , C07C233/60 , C07C233/62 , C07C255/44 , C07C255/56 , C07C275/30 , C07C317/32 , C07C323/40 , C07C2601/02 , C07C2603/74 , C07D207/09 , C07D207/27 , C07D209/08 , C07D209/86 , C07D209/88 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/89 , C07D233/24 , C07D233/64 , C07D257/04 , C07D263/58 , C07D277/42 , C07D277/46 , C07D277/82 , C07D295/027 , C07D295/13 , C07D295/30 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D487/04
摘要: The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
摘要翻译: 本发明涉及取代的金刚烷化合物,其药物组合物,其制备方法和抑制鞘氨醇激酶以及治疗或预防过度增殖性疾病,炎性疾病或血管生成疾病的方法。
-
公开(公告)号:US20120095004A1
公开(公告)日:2012-04-19
申请号:US13277044
申请日:2011-10-19
申请人: Charles D. Smith , Kevin J. French , Yan Zhuang
发明人: Charles D. Smith , Kevin J. French , Yan Zhuang
IPC分类号: A61K31/5375 , A61K31/277 , A61K31/445 , A61K31/495 , A61K31/40 , A61K31/44 , A61K31/4164 , A61K31/404 , A61K31/41 , A61K31/403 , A61K31/426 , A61K31/428 , A61K31/423 , A61K31/52 , A61K31/19 , A61K31/12 , A61K31/215 , A61P35/00 , A61P9/10 , A61P17/06 , A61P1/00 , A61P19/02 , A61P11/06 , A61P37/08 , A61P13/12 , A61P11/00 , A61P17/00 , A61P27/02 , A61K31/16
CPC分类号: C07C61/39 , C07C49/323 , C07C49/563 , C07C49/567 , C07C49/573 , C07C61/40 , C07C69/738 , C07C211/27 , C07C211/29 , C07C211/48 , C07C211/52 , C07C215/76 , C07C217/58 , C07C217/60 , C07C233/49 , C07C233/59 , C07C233/60 , C07C233/62 , C07C255/44 , C07C255/56 , C07C275/30 , C07C317/32 , C07C323/40 , C07C2601/02 , C07C2603/74 , C07D207/09 , C07D207/27 , C07D209/08 , C07D209/86 , C07D209/88 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/89 , C07D233/24 , C07D233/64 , C07D257/04 , C07D263/58 , C07D277/42 , C07D277/46 , C07D277/82 , C07D295/027 , C07D295/13 , C07D295/30 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D487/04
摘要: The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
摘要翻译: 本发明涉及取代的金刚烷化合物,其药物组合物,其制备方法和抑制鞘氨醇激酶以及治疗或预防过度增殖性疾病,炎性疾病或血管生成疾病的方法。
-
公开(公告)号:US20080167352A1
公开(公告)日:2008-07-10
申请号:US11963838
申请日:2007-12-23
申请人: Charles D. Smith , Kevin J. French , Yan Zhuang
发明人: Charles D. Smith , Kevin J. French , Yan Zhuang
IPC分类号: A61K31/4409 , C07D211/70 , A61P35/00 , A61P9/10
CPC分类号: C07C61/39 , C07C49/323 , C07C49/563 , C07C49/567 , C07C49/573 , C07C61/40 , C07C69/738 , C07C211/27 , C07C211/29 , C07C211/48 , C07C211/52 , C07C215/76 , C07C217/58 , C07C217/60 , C07C233/49 , C07C233/59 , C07C233/60 , C07C233/62 , C07C255/44 , C07C255/56 , C07C275/30 , C07C317/32 , C07C323/40 , C07C2601/02 , C07C2603/74 , C07D207/09 , C07D207/27 , C07D209/08 , C07D209/86 , C07D209/88 , C07D211/58 , C07D213/38 , C07D213/40 , C07D213/89 , C07D233/24 , C07D233/64 , C07D257/04 , C07D263/58 , C07D277/42 , C07D277/46 , C07D277/82 , C07D295/027 , C07D295/13 , C07D295/30 , C07D317/58 , C07D333/20 , C07D333/22 , C07D333/28 , C07D487/04
摘要: The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
摘要翻译: 本发明涉及取代的金刚烷化合物,其药物组合物,其制备方法和抑制鞘氨醇激酶以及治疗或预防过度增殖性疾病,炎性疾病或血管生成疾病的方法。
-
公开(公告)号:US07220764B2
公开(公告)日:2007-05-22
申请号:US10462954
申请日:2003-06-17
申请人: Charles D. Smith , Kevin J. French , Jong K. Yun
发明人: Charles D. Smith , Kevin J. French , Jong K. Yun
IPC分类号: A61K31/426
CPC分类号: A61K31/41
摘要: The invention relates to compositions and methods for inhibiting sphingosine kinase and for treating hyperproliferative disease.
摘要翻译: 本发明涉及抑制鞘氨醇激酶和治疗过度增殖性疾病的组合物和方法。
-
公开(公告)号:US08324237B2
公开(公告)日:2012-12-04
申请号:US11437988
申请日:2006-05-19
IPC分类号: A61K31/44 , A61K31/425
CPC分类号: A61K31/685
摘要: The invention includes processes mainly for the treatment of a inflammatory diseases, such as inflammatory bowel disease, arthritis, atherosclerosis, asthma, allergy, inflammatory kidney disease, circulatory shock, multiple sclerosis, chronic obstructive pulmonary disease, skin inflammation, periodontal disease, psoriasis and T cell-mediated diseases of immunity, including allergic encephalomyelitis, allergic neuritis, transplant allograft rejection, graft versus host disease, myocarditis, thyroiditis, nephritis, systemic lupus erthematosus, and insulin-dependent diabetes mellitus. The processes involve treating a patient with a pharmaceutical composition containing an active ingredient that inhibits the activity of sphingosine kinase.
摘要翻译: 本发明包括主要用于治疗诸如炎性肠病,关节炎,动脉粥样硬化,哮喘,变态反应,炎症性肾病,循环性休克,多发性硬化,慢性阻塞性肺疾病,皮肤炎症,牙周病,牛皮癣和炎症性疾病 T细胞介导的免疫疾病,包括过敏性脑脊髓炎,过敏性神经炎,移植异种移植排斥反应,移植物抗宿主病,心肌炎,甲状腺炎,肾炎,系统性红斑狼疮和胰岛素依赖性糖尿病。 该方法包括用含有抑制鞘氨醇激酶活性的活性成分的药物组合物治疗患者。
-
公开(公告)号:US20100137315A1
公开(公告)日:2010-06-03
申请号:US12627812
申请日:2009-11-30
申请人: Charles D. Smith , Kevin J. French , Zuping Xia
发明人: Charles D. Smith , Kevin J. French , Zuping Xia
IPC分类号: A61K31/5377 , C07D277/20 , A61K31/426 , C07D417/02 , C07D401/02 , A61K31/454 , A61P35/00 , A61P29/00 , A61P9/00
CPC分类号: C07C233/75 , C07D207/09 , C07D211/38 , C07D211/58 , C07D213/40 , C07D263/58 , C07D277/42 , C07D277/46 , C07D277/48 , C07D277/56 , C07D277/82 , C07D417/02 , C07D417/12
摘要: The invention relates to compounds, pharmaceutical compositions thereof, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
摘要翻译: 本发明涉及化合物,其药物组合物和抑制鞘氨醇激酶以及治疗或预防过度增殖性疾病,炎性疾病或血管生成疾病的方法。
-
-
-
-
-
-
-